Literature DB >> 9065550

Patterns of recovery in the Guillain-Barre syndromes.

T W Ho1, C Y Li, D R Cornblath, C Y Gao, A K Asbury, J W Griffin, G M McKhann.   

Abstract

Clinical, electrodiagnostic, and pathologic studies indicate that the Guillain-Barre syndromes (GBSs) include both primary demyelinating and primary axonal forms. The axonal forms are usually thought to have a poorer prognosis, with less chance for rapid or complete recovery. In northern China, epidemics of one axonal form, acute motor axonal neuropathy (AMAN), occur annually in the summer. Autopsy studies in some fatal cases have demonstrated wallerian-like degeneration of motor roots and motor fibers in the peripheral nerves. Recovery of such patients would require axonal regeneration along the entire length of the nerve fiber. In a 2-year prospective study of GBS at a single hospital in northern China, 42 patients were classified as having either AMAN (32 patients), acute inflammatory demyelinating polyneuropathy (AIDP) (8 patients), or as undetermined (2 patients) by electrodiagnostic criteria. Their recoveries were monitored clinically. The recovery times of AMAN and AIDP patients were similar: the median time to regain the ability to walk 5 meters with assistance was 31 days for patients classified as having AMAN and 32 days for those classified as having AIDP. These rapid recovery times are incompatible with severe wallerian degeneration of the ventral roots and motor nerve fibers. The rapid recoveries observed in AMAN patients could be explained by relatively quickly reversible immune-mediated changes at nodes of Ranvier in motor fibers, by degeneration and regeneration of intramuscular motor nerve terminals, or both.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9065550     DOI: 10.1212/wnl.48.3.695

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  17 in total

Review 1.  Progress in inflammatory neuropathy -the legacy of Dr Jack Griffin.

Authors:  Eva L Feldman; Richard A C Hughes; Hugh J Willison
Journal:  Nat Rev Neurol       Date:  2015-10-13       Impact factor: 42.937

2.  EMG and duration of ventilatory support in children with Guillain-Barre syndrome.

Authors:  Fernando Ortiz-Corredor; Jorge Díaz-Ruiz; Alvaro Izquierdo-Bello
Journal:  Childs Nerv Syst       Date:  2006-03-25       Impact factor: 1.475

Review 3.  Diagnosis of acute neuropathies.

Authors:  Clarissa Crone; Christian Krarup
Journal:  J Neurol       Date:  2007-09-21       Impact factor: 4.849

Review 4.  Immunotherapy of Guillain-Barré syndrome.

Authors:  Shuang Liu; Chaoling Dong; Eroboghene Ekamereno Ubogu
Journal:  Hum Vaccin Immunother       Date:  2018-07-12       Impact factor: 3.452

5.  Isolated absence of F waves and proximal axonal dysfunction in Guillain-Barré syndrome with antiganglioside antibodies.

Authors:  S Kuwabara; K Ogawara; K Mizobuchi; M Koga; M Mori; T Hattori; N Yuki
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-02       Impact factor: 10.154

6.  Rate of progression of Guillain-Barré syndrome is not associated with the short-term outcome of the disease.

Authors:  Mirjana Arsenijević; Ivana Berisavac; Branka Mladenović; Predrag Stanarčević; Dejana Jovanović; Dragana Lavrnić; Stojan Peric
Journal:  Ir J Med Sci       Date:  2020-07-14       Impact factor: 1.568

7.  Guillain-Barré syndrome in children: subtypes and outcome.

Authors:  Zeynep Selen Karalok; Birce Dilge Taskin; Zeliha Brohi Yanginlar; Esra Gurkas; Alev Guven; Aydan Degerliyurt; Ece Unlu; Gulsen Kose
Journal:  Childs Nerv Syst       Date:  2018-06-14       Impact factor: 1.475

8.  Recovery patterns and long term prognosis for axonal Guillain-Barré syndrome.

Authors:  A Hiraga; M Mori; K Ogawara; S Kojima; T Kanesaka; S Misawa; T Hattori; S Kuwabara
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-05       Impact factor: 10.154

9.  Assessment of autonomic dysfunction in childhood guillain-barré syndrome.

Authors:  Mahmood Samadi; Babak Kazemi; Sona Golzari Oskoui; Mohammad Barzegar
Journal:  J Cardiovasc Thorac Res       Date:  2013-10-05

Review 10.  Guillain-Barré syndrome: epidemiology, pathophysiology and management.

Authors:  Satoshi Kuwabara
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.